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Background/aim: Our objective was to identify the antioxidant properties of honeybee products from Turkey, chestnut honey, pollen,
propolis, and royal jelly, and their hepatoprotective activity against CCl4-induced hepatic damage in rats.
Materials and methods: Animals were fed with honeybee products for 7 days following CCl4 injection. Development of liver damage
and oxidative stress were monitored by measuring the activities of the enzymes alanine transaminase, aspartate transaminase,
malondialdehyde, superoxide dismutase, and catalase. Antioxidant capacities of the bee products were identified using FRAP and DPPH
assays, as well as by measuring total phenolic and flavonoid contents.
Results: The antioxidant activities of the honeybee products were highest in propolis, followed, in order, by pollen, honey, and royal
jelly. Despite their different levels of antioxidant capacity, their roles in the prevention of liver damage induced by CCl4 were very similar,
which can be explained through their bioavailability to the treated animals.
Conclusions: Our results suggest that honey, propolis, pollen, and royal jelly significantly enhanced the healing of CCl4-induced liver
damage, partially due to their antioxidant properties and bioavailability.
Key words: Liver damage, honey, pollen, propolis, royal jelly, apitherapy

1. Introduction
The liver is a crucially important organ of the gastrointestinal
tract, in which all the metabolic activities and detoxification
of xenobiotics take place (1,2). Fatty liver, alcohol, viral
and bacterial infections, and several chemical agents such
as pesticides, drugs, and heavy metals cause liver damage.
Acute and chronic viral hepatitis, alcoholic steatosis,
fibrosis, cirrhosis, and hepatocellular carcinoma are some
of the major liver diseases, from which millions of patients
suffer worldwide (2–4). Although there are some chemical
medications for treating liver diseases, clinicians prefer
plants or artificially modified versions of natural products,
such as silymarin, curcimin, resveratrol, and naringenin,
in order to avoid further hepatic complications (2,5,6).
Several animal studies have also demonstrated that natural
products can effectively inhibit liver damage and treat
hepatic diseases (2,5,7).
* Correspondence: otarhan@artvin.edu.tr
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Hepatic injuries in animal models are induced
by various chemicals, such as carbon tetrachloride
(CCl4), ethanol, pesticides, galactosamine, analgesics
(acetaminophen), antipyretic drugs, and heavy metal ions
(Hg2+, Pb2+) (7,8). CCl4 is a highly toxic agent metabolized
by the cytochrome P450 system, which releases reactive
trichloromethyl free radicals and reactive oxygen species,
thus initiating lipid peroxidation and cellular necrosis
(9,10). According to several reports, CCl4-induced liver
damage affects various organelles of the hepatocyte cells
and primarily the mitochondria. Mitochondrial damage
in hepatocytes is monitored in a simple way by measuring
mitochondrial enzyme activities such as alanine
transaminase (ALT), aspartate transaminase (AST), or
gamma-glutamyl transferase (GGT) in serum or plasma.
Histopathological examination of the liver is also used for
the detection of liver injuries (5).
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Apitherapy, which uses bee products, has been
employed in traditional medicine for the prevention and
treatment of many diseases, such as systemic immune
diseases, allergic diseases, viral diseases, and organ-specific
inflammatory diseases, since ancient times (11). The main
apitherapy products are honey, pollen, propolis, and royal
jelly (RJ). These contain compounds with high biological
activity such as polyphenols (phenolic acids, flavonoids,
anthocyanins), vitamins, essential oils, and minerals
(12–14). During the last 2 decades, research into the role
of apitherapic products for the prevention and treatment
of human diseases has intensified, and their antioxidant,
antibacterial, antitumoral, and antiinflammatory
potentials have been revealed (11,15,16).
Honey, pollen, propolis, and RJ contain a variety of
secondary metabolites that are obtained from the plants
visited by the honeybee. In general, the term “secondary
metabolites of natural products” includes the phenolic
compounds, which function in plant defense mechanisms
against microorganisms, insects, and herbivores (2,17).
Honey is a sweet food collected from the nectar of flower
blossoms or the secretions of scale insects. Sugars are
the main constituents of honey (95% dry weight), others
being organic materials (phenolic substances, organic
acids, vitamins, proteins, and minerals) (17). Bee pollen is
located at the male gametes of the flower blossom, collected
by honeybees in a process of great importance for plant
reproduction (18). Bee pollen is a well-balanced food, rich
in amino acids, proteins, carbohydrates, fats, minerals,
and phenolic substances and used in the honeybees’ diet
and to feed larvae (19). Several studies have shown that
bee pollen extracts protect human cells from oxidative
stress (18–20). Bee pollen extracts of Schisandra chinensis
have been reported to exhibit significant protective effects
against acute hepatotoxicity induced by CCl4 in mice
(18). Propolis is a natural resinous product, collected by
honeybees from various plant sources such as buds, the
barks of some trees, and plants. Its resinous structure is
changed and it is stored inside the hive (21). Propolis
contains a high percentage of phenolic compounds,
such as caffeic acid and caffeic acid phenethyl ester
(CAPE), which is its most active component. Many
beneficial properties of CAPE have been reported,
including antioxidant, antiinflammatory, antibacterial,
antitumoral, anticarcinogenic, and immunomodulatory
effects (11,22,23). RJ, which represents the major nutrient
of the young larvae, is a secretory product from the
salivary glands of the worker honeybees. The composition
of RJ is approximately 12%–15% proteins, 12%–15%
carbohydrates, and 5%–6% lipids, as well as vitamins,
minerals, and sterols (11,24,25). RJ has been reported to
possess various bioactive components that reduce liver
damage and induce proliferation of hepatocytes (15,26).

A previous study of ours showed that chestnut pollen
ameliorates hepatic damage induced with CCl4 in rats and
attributed its healing effects to high silibinin levels (27).
The aim of this study was to investigate the role of other bee
products in preventing liver damage induced with CCl4.
We induced liver damage in rats through injections of CCl4
and fed them with chestnut honey, pollen, propolis, and RJ
to treat the resulting hepatic damage. We also investigated
the antioxidant potential of these products by measuring
the total phenolic contents and the ferric-reducing
antioxidant assay (FRAP) and DPPH (2,2-diphenyl-1picrylhydrazyl) radical scavenging activity. Development
of liver damage was monitored by measuring the activities
of ALT, AST, superoxide dismutase (SOD), and catalase
(CAT) enzymes and malondialdehyde (MDA) levels, as
well as histopathological examinations. The antioxidant
potential of the bee products was correlated with their total
phenolic contents. Propolis exhibited the highest potential,
followed by pollen, honey, and RJ, in that order. However,
these 4 bee products exhibited the same efficiency in the
treatment of hepatocyte injury induced by CCl4.
2. Materials and methods
2.1. Chemicals and samples
The chemicals used were of analytical purity. Methanol,
ethanol, thiobarbituric acid (TBA), trichloroacetic
acid (TCA), and 1,1,3,3-tetramethoxypropane were
procured from Sigma-Aldrich Chemie GmbH
(Steinheim, Germany) and Merck (Darmstadt, Germany).
Butylated hydroxytoluene (BHT) was from AppliChem
(Darmstadt, Germany) and Trolox (6-hydroxy-2,5,7,8tetramethylchroman-2-carboxylic acid) and quercetin
were also procured from Sigma-Aldrich Chemie GmbH,
while 2,2-diphenyl-1-picrylhydrazyl (DPPH), Folin–
Ciocalteu phenol reagent, and 2,4,6-tri-(2-pyridyl)-striazine (TPTZ) were purchased from Fluka Chemie
GmbH (Buchs, Switzerland). Nitro blue tetrazolium
(NBT), xanthine, and xanthine oxidase were purchased
from Sigma Chemical Co. (St. Louis, MO, USA). AST and
ALT diagnostic kits were also purchased from Sigma. Olive
oil was obtained from Komili Sızma Company (İzmir,
Turkey).
Chestnut honey, pollen, and propolis samples were
obtained from experienced beekeepers belonging to
the Zonguldak Beekeepers’ Association in the Black Sea
region of Turkey. Palynological identification showed that
Castanea sativa L. pollens were the dominant pollens (65%)
in the pollen and honey (89%) samples. RJ was obtained
from Macahel Apiculture Co. Ltd. (Artvin, Turkey). All
samples were from the 2010 season.
2.2. Preparations of the bee samples for antioxidant tests
Approximately 5 g of dried pollen samples was placed in a
100-mL Falcon tube, and 100 mL of methanol was added
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and then stirred with a shaker (Heidolph Promax 2020,
Schwabach, Germany) for 24 h at room temperature. After
shaking, the mixture was sonicated in a sonicator apparatus
(Elma Transsonic Digital, Germany) for 3 h. After
sonication, the suspension was filtered, and the filtrate was
concentrated in a rotary evaporator (IKA-Werke, Staufen,
Germany) under reduced pressure at 40 °C. The residue
was resolved to a minimal volume in methanol and was
kept at 4 °C until use. The same procedure was followed
for the honey samples. Raw propolis samples were initially
frozen at –20 °C and ground to a fine powder. Next, 5.0 g of
powder was placed in a Falcon tube (50 mL) and 30 mL of
methanol was added. The suspensions were continuously
stirred with a shaker at room temperature for 24 h and
sonicated for 3 h. The suspensions were then filtered with
a filter paper and concentrated in a rotary evaporator
(IKA-Werke) under reduced pressure at 40 °C. The residue
was resolved to a minimal volume in methanol and kept
at 4 °C until use. Ten grams of raw RJ was dissolved in 50
mL of methanol and stirred at room temperature for 6 h.
The suspension was centrifuged, and the supernatant was
evaporated in a rotary evaporator (IKA-Werke) at 40 °C.
The residue was resolved in minimal ethanol and kept at
4 °C until use.
2.3. Preparation of the bee samples for animal feedings
Honey, pollen, and RJ samples were diluted with distilled
water and administered to the rats orally by gavage. Propolis
samples were prepared in 95% ethanol, after which the
alcohol degree was reduced to 24% through dilution. The
doses administered to the animals were 400 mg/kg honey,
pollen, and propolis and 50 mg/kg RJ. CCl4 was diluted
with olive oil (1:1, v/v) and injected intraperitoneally (i.p.).
2.4. Animals and preparation doses
The protocol for this study was approved by the Ethics
Committee on Animal Research of Karadeniz Technical
University in Turkey (protocol number: 2010/603.05.2010). Forty-nine adult female Sprague Dawley
rats weighing 250–300 g were obtained from the Surgical
Experimental Research Center (Trabzon, Turkey) and
housed in a room under controlled temperature (22 ± 2 °C)
in a 12-h light/dark cycle. The rats were fed with standard
laboratory chow and water during the experiment. They
were divided into 7 equal groups (n = 7). The experimental
applications were completed in 7 days.
Experimental design:
Group 1: Saline solution/control group: 0.8 mL/kg, i.p.
Group 2: Ethanol/control group: 0.8 mL/kg, i.p.
Group 3: CCl4 only/untreated group: 0.8 mL/kg, i.p.
Group 4: Honey treatment group: CCl4 (0.8 mL/kg,
i.p.) with 400 mg/kg honey, gavage.
Group 5: Pollen treatment group: CCl4 (0.8 mL/kg, i.p.)
with 400 mg/kg pollen, gavage.
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Group 6: Propolis treatment group: CCl4 (0.8 mL/kg,
i.p.) with 400 mg/kg propolis, gavage.
Group 7: RJ treatment group: CCl4 (0.8 mL/kg, i.p.)
with 50 mg/kg RJ, gavage.
Twenty-four hours after the last injection the rats
were sacrificed by decapitation. The abdominal cavity was
exposed via a midline incision and the liver was quickly
removed. Two random specimens from each group were
taken for microscopy examination and the remaining
livers were divided into 2 pieces and kept in 1.15% KCl
solution and 10% formaldehyde for histopathological
examination.
2.5. Determination of antioxidant capacity
Total phenolic contents (TPCs) of the samples were
determined by the Folin–Ciocalteu method using gallic
acid as the standard (28). The amount of total flavonoid
was determined using the spectrometric method with
aluminum chloride (29) and quercetin as a standard.
The reducing ability of ferric tripyridyltriazine (FeIII-TPTZ) complex, the FRAP assay, was used for total
antioxidant capacity measurement (30). Working FRAP
reagent was prepared as required by mixing 25 mL of 300
mM acetate buffer, pH 3.6, with 2.5 mL of 10 mM TPTZ
solution in 40 mM HCl and 2.5 mL of 20 mM FeCl3·6H2O
solution. Next, 3 mL of freshly prepared FRAP reagent and
100 µL of the samples were mixed and incubated for 4 min
at 37 °C, and the absorbance was read at 595 nm against
a reagent blank containing distilled water. Trolox was
used as a positive control to construct a reference curve
(62.5–1000 µM). FRAP values were expressed as µmol
FeSO4.7H2O equivalent/g.
The scavenging of DPPH radicals was assayed using
the Molyneux method (31). This method is based on
the fact that the DPPH radical has a purple color that
decays in the presence of antioxidant agents. The change
in absorbance can be monitored at 517 nm in order to
detect radical scavenging activity. For each sample, 1.5
mL of the ethanol extract solution was mixed with 1.5 mL
of 0.1 mM DPPH (dissolved in methanol), vortexed, and
incubated for 50 min in the dark at room temperature. The
absorbance was recorded at 517 nm against a blank and
a control. The control solution contained DPPH solution
without sample. The results were expressed as SC50 (mg/
mL), which was calculated from the curves by plotting
absorbance values, and the SC50 values represent the
concentration of the extract (mg/mL) required to inhibit
50% of the radicals.
2.6. Biochemical analysis
The SOD activity of plasma and liver tissue was determined
by spectrometric assay, using NBT reagents following the
method described by Sun et al. (32). The protocol is based
on the measurement of absorbance at 560 nm (BeckmanCoulter, DU 530) of the blue-colored formazan product
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generated as a result of the reduction of the NBT ion by
the superoxide radical. Enzyme activity causing 50%
inhibition was regarded as 1 unit using bovine SOD as the
standard, and the result was expressed as U/g tissue (32).
MDA levels were measured with a colorimetric test
with TBA, which is used to assess endogenous lipids (33).
Fresh tissue samples obtained from the treated rats were
kept at –80 °C until analysis. Liver tissues were weighed
and homogenized in ice-cold 1.15% KCl. The homogenate
was centrifuged at 2000 × g for 10 min. The breakdown
product of 1,1,3,3-tetramethoxypropane was used as the
standard and tissue MDA levels were calculated as nmol/
mL plasma/g tissue.
CAT activity was determined using the method
described by Aebi (34). Decomposition of H2O2 was
monitored at the absorbance of 240 nm.
2.7. Histopathological analysis
For histopathological analysis, the liver tissue samples
were immediately fixed in 10% formaldehyde solution,
dehydrated with ethanol series, cleared with xylene,
embedded in paraffin, and sectioned. Next, 5-µm tissue
sections were stained with hematoxylin and eosin (H&E)
and examined under a light microscope (Olympus BX51; Olympus Optical Co., Ltd., Tokyo, Japan). All liver
tissue slides were examined under high magnification,
and images were recorded by a blinded histologist.
Liver sections from each study group were evaluated for
structural changes. Liver damage severity was assessed
semiquantitatively using the following criteria: hepatocyte
degeneration, vascular congestion, sinusoidal dilatation,
congestion in enlarged sinusoids, and fatty degeneration.
Each specimen was scored on a scale of 0 to 3 (0: none,
1: mild, 2: moderate, 3: severe). A mean histological score
was calculated for each group.

2.8. Statistical analysis
Statistical calculations were performed with SPSS 15.0
for Windows and Microsoft Excel for Windows XP. The
results are presented as mean ± standard deviation (SD).
One-way analysis of variance was used for evaluation of
values. The mean values found to be statistically different
from each other were compared using Duncan’s multiple
comparison test. P < 0.05 was regarded as statistically
signiﬁcant.
3. Results
3.1. Antioxidant potential of the honeybee products
The antioxidant values of bee products used in the study
are summarized in Table 1. The TPCs of the honeybee
samples were measured using the commonly used Folin
assay for the methanolic extracts. We found significant
differences in the amounts of TPC among the honeybee
products tested, ranging between 0.072 mg GAE/g (RJ)
and 183 mg GAE/g (propolis) in raw samples (P < 0.01). In
descending order, based on TPC, it was propolis > pollen
> honey > RJ. Propolis exhibited the highest TPC and RJ
the lowest. Similar to total phenolic substances, propolis
samples exhibited the highest total flavonoid contents
(TFCs) and RJ samples the lowest.
The reducing ability of the Fe-III-TPTZ complex
reflects the total antioxidant capacity of honeybee
products. In this method, higher FRAP values indicate
higher antioxidant activity. The calculated FRAP values
of the samples are given in Table 1, and they ranged from
1.02 to 1416 µmol FeSO4.7H2O/g sample. The ranking was
similar to that recorded for TPC and TFC, i.e. propolis,
pollen, honey, and RJ.
The antioxidant potential of the bee product samples
can also be measured through their DPPH radical

Table 1. Total phenolic and flavonoid contents (TPCs and TFCs) of the studied honeybee products representing their antioxidant
potential (FRAP and DPPH).
Honeybee
product

TPC
(mg GAE/g)

TFC
(mg quercetin/g)

FRAP
(µmol FeSO4.7H2O/g)

DPPH
(mg/mL)

Honey
Sig.

0.95 ± 0.07a
0.833

0.56 ± 0.03a
0.291

1.02 ± 0.02a
0.143

19.64 ± 1.45c
1.000

Pollen
Sig.

13.78 ± 0.34c
1.000

1.64 ± 0.11b
0.121

48.75 ± 2.60b
0.118

0.49 ± 0.01b
1.000

Propolis
Sig.

183.86 ± 6.35d
1.000

106.61 ± 2.36c
0.097

1416.20 ± 0.07c
1.000

0.02 ± 0.00a
1.000

Royal jelly
Sig.

0.072 ± 0.05b
1.000

0.02 ± 0.00d
1.000

0.95 ± 0.06a
0.143

38.72 ± 3.20d
1.000

F

158.331

155.359

143.493

110.942

a, b, c, d: The values with different letters are significantly different from each other (P < 0.01).
FRAP: Ferric-reducing antioxidant assay.
DPPH: 2,2-Diphenyl-1-picrylhydrazyl radical scavenging activity.
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scavenging ability. The results were expressed as SC50 (mg/
mL) values and the lower SC50 values represent higher
radical scavenging activity. All the bee products scavenged
the DPPH radicals, but there were considerable differences
among the studied samples. The propolis and pollen
samples exhibited higher radical scavenging activity than
the honey and RJ samples (Table 1).
3.2. Physiological findings
We detected no major physical disorders or weight loss
in the control and treatment groups, except for weight
loss (3.65%) in the CCl4-only treated rats (Group 3).
The honey- and RJ-treated groups (Group 5 and Group
6, respectively) remained at the same weight, while the
pollen- and propolis-treated groups (Group 4 and Group
7, respectively) both gained weight by the end of the
treatment. The relevant results are given in Table 2.
We measured ALT and AST enzyme activity in plasma
in order to determine whether CCl4 attenuated the liver
damage in the CCl4-treated rats (Table 2). AST and ALT
enzyme activities of Group 3 were significantly higher than
in the control groups (Groups 1 and 2), approximately 6
and 17 times higher, respectively. AST and ALT enzyme
activities decreased significantly in the rats fed with the
bee products (pollen, propolis, honey, and RJ; Groups 4–7)
following CCl4 administration. However, none of these
treatment groups differed significantly from one another
in terms of lowering AST and ALT enzyme activity.

We measured MDA levels and SOD and CAT enzyme
activity using liver and plasma samples in order to
determine changes in antioxidant activity at the cellular
level (Table 2). The liver MDA levels increased significantly
in rats treated with CCl4 only (Group 3); however, MDA
levels remained close to control group levels in animals
fed with the bee products (Groups 4–7). Among the
treatment groups, the group receiving propolis (Group
6) had the lowest MDA levels, followed by the pollen and
honey groups (Groups 5 and 4), in that order. Nonetheless,
RJ treatment partially reversed oxidative stress induced
by CCl4 treatment. We also measured MDA levels in
the rat plasma samples. However, those findings were
below the detection limits and the results were omitted
from Table 2. Similar to MDA measurements, liver SOD
activity increased only in CCl4-treated rats (Group 3) and
decreased to close to control levels following honeybee
product treatments (Groups 4–7), although the changes
in plasma did not achieve any significance. CAT activities
increased in the groups receiving CCl4 treatment,
representing higher liver damage, and increased slightly
in the honeybee product-treated groups compared to the
control group (Group 6).
Since propolis is not water-soluble, we used ethanolic
propolis extracts. In order to identify the effect of
ethanol on liver markers, antioxidant enzymes, and lipid
peroxidation, we established an ethanol group (Group 2)

Table 2. The enzyme analysis of the animal samples treated with the honeybee products following CCl4-induced liver damage.
ALT
plasma
(U/L)

MDA
(liver)

+4.21 ± 0.90a 220 ± 46a
0.101
0.419

61 ± 10a
0.818

Ethanol

–0.93 ± 0.03b 179 ± 31a
0.059
0.419

G3
Sig.

CCl4
(0,8 mL/kg)

G4
Sig.

Treatment groups
(n = 7)

Weight
change (%)

G1
Sig.

0.9 %SF
Control

G2
Sig.

AST
(U/L)

SOD (U)

CAT (kU/L)

Plasma
(U/mL)

Liver
U/g tissue

Plasma
(U/mL)

Liver
(U/g tissue)

9.28 ± 1.00a
1.000

0.16 ± 0.14a
0.235

1.39 ± 0.30a
1.000

1.28 ± 1.09a
0.187

22.78 ± 2.20a
0.127

54 ± 6.0a
0.818

11.24 ± 0.40b
0.399

0.04 ± 0.06a
0.235

1.75 ± 0.34b
1.000

2.20 ± 0.56a
0.187

24.18 ± 2.65a
0.127

–3.65 ± 0.80c 1303 ± 225c
1.000
1.000

1080 ± 20c
1.000

21.23 ± 1.19f
1.000

0.02 ± 0.04a
0.235

6.40 ±1.09f
1.000

2.55 ± 0.08a
0.187

34.05 ± 4.40b
0.610

Honey
(400 mg/kg)

+3.42 ± 0.68a 424 ± 110b
0.101
0.520

199 ± 56b
0.514

14.03 ± 0.42e
1.000

0.09 ± 0.05a
0.235

4.41 ± 2.22e
0.377

1.98 ± 0.50a
0.187

25.20 ± 3.21a
0.127

G5
Sig.

Pollen
(400 mg/kg)

–2.29 ± 0.52c 445 ± 140b
1.000
0.520

222 ± 120b
0.514

12.50 ± 0.50e
1.000

0.11 ± 0.07a
0.235

4.33 ± 1.23e
0.377

1.65 ± 0.56a
0.187

27.46 ± 2.80a
0.127

G6
Sig.

Propolis
(400 mg/kg)

–2.78 ± 0.70c 409 ± 68b
1.000
0.520

205 ± 42b
0.514

10.71 ± 0.70c
0.058

0.12 ± 0.06a
0.235

3.52 ± 0.35c
1.000

1.16 ± 0.92a
0.187

24.50 ± 3.60a
0.127

G7
Sig.

Royal Jelly
(50 mg/kg)

+3.17 ± 0.64a 410 ± 112b
0.101
0.520

204 ± 73b
0.514

16.65 ± 0.65d
1.000

0.07 ± 0,05a
0.235

3.85 ± 0.67d
1.000

1.89 ± 0.23a
0.187

28.01 ± 3.42a
0.127

5.363

37.617

171.750

4.345

2.376

0.943

2.484

F

31.079

a, b, c, d: The values with different letters are significantly different from each other (P < 0.05). G = Group.

198

SARAL et al. / Turk J Med Sci
dilatation were observed (Figures 1B and 1C). In the
honey-treated group (Group 4), a decrease in intracellular
fatty degeneration was observed, especially around the
portal area (Figure 1D). In the pollen and the propolis
groups (Groups 5 and 6), common intracellular fatty
degeneration was observed around the central veins, but
normal hepatocytes were present around the portal area
(Figures 2A and 2B). In the RJ-treated group (Group 7),
minimal intracellular fatty degeneration was observed
around the central veins, although extensive abnormal
hepatocytes were present in the same regions (Figure 2C).

(0.8 mL kg–1 day–1) for control purposes. Ethanol treatment
did not change AST and ALT enzyme activity in plasma,
but it significantly altered the MDA level and SOD and
CAT enzyme activities in the liver compared to the control
group (Group 1).
3.3. Histopathological findings
We analyzed the liver tissue sections from the study
groups using light microscopy (Figure 1). Liver tissue was
histologically normal in the control group (Figure 1A).
In the ethanol and CCl4-treated groups (Groups 2 and 3),
extensive intracellular fatty degeneration and sinusoidal

A

B

C

D

Figure 1. Photomicrograph of liver sections. A) Normal histological appearance of hepatocytes (↑) in control group (Group 1). B)
Significant dilatation in sinusoids (↑) and increased intracellular fatty degeneration (▲) in ethanol-treated group (Group 2). C)
Significant dilatation in sinusoids (↑) and common increased intracellular fatty degeneration (▲) in CCl4-only group (Group 3). D)
Normal hepatocytes (↑) and intracellular fatty degeneration around the central veins (▲) in honey-treated group (Group 4). H&E, 200×.

A

B

C
Figure 2. Photomicrograph of liver sections. A) Normal hepatocytes (↑) and intracellular fatty degeneration around the central veins
(▲) in pollen-treated group (Group 5). B) Normal hepatocytes (↑), increased fatty degeneration (▲), and sinusoidal dilatation (★)
in propolis-treated group (Group 6). C) Extensive normal hepatocytes (↑) and rare intracellular fatty degeneration around the central
veins (▲) in RJ-treated group (Group 7). H&E, 200×.
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4. Discussion
Liver diseases are one of the most common illnesses in
the world, from which hundreds of millions of people
suffer and die each year. Liver damage is primarily caused
by viral infections, such as hepatitis B, hepatitis C, and
the human immunodeficiency virus, as well as bacterial
infections, chemical agents, antibiotics, and pesticides
(1,5,7,8). Since the liver is a major organ that processes
food and most medications, natural medicines, such as
milk thistle (silymarin) and dandelion, are preferred over
chemical drugs for treating liver damage (6,14). Several
clinical studies have used natural medicines, which are
rich in secondary metabolites such as phenolic agents, to
treat liver disorders. In recent decades, apitherapy, the use
of bee products for healing, has also been used to treat liver
disorders (7,14,15). In our study, we tested and compared
the potentials of various bee products in different samples
in the treatment of CCl4-induced liver damage in rats.
Before experimental investigation of their
hepatoprotective roles in rats, we evaluated the antioxidant
properties of the honeybee products. Most honeybee
products exhibit biological properties such as antioxidant,
antibacterial, antitumoral, and antiinflammatory activities,
which are mostly associated with phenolic acids, flavonoids,
anthocyanins, and several aromatic acids and esters within
them (35). The phenolic contents of natural medicines
have been identified as the major agents involved in
counteracting reactive oxygen species in the healing of the
damaged liver (17). We initially analyzed TPC and various
antioxidant properties of the honeybee products in order
to compare relations between structure and liver healing.
Propolis contained the highest TPC (183.86 mg GAE/g)
and RJ the lowest (0.072 mg GAE/g). In our previous
study, the TPC levels were between 115 and 210 mg GAE/g
in Turkish propolis (21). TPC in all bee products, as well
as other antioxidant substances, largely depends on the
geographical location and biodiversity involved (36,37).
Ulusoy and Kolayli (38) reported TPC levels between 44
and 124 mg GAE/g in Anzer pollen samples from Turkey.
In another study, TPC levels in Sonoran Desert pollen
were reported as being between 5.91 and 34.85 mg GAE/g
(19). In parallel to the TPC levels, TFC levels were highest
in propolis, followed by pollen, honey, and RJ, in that
order. In association with its phenolic structures, propolis
exhibited the highest antioxidant capacity, as well as the
highest FRAP value (1416.2 µmol FeSO4.7H2O/g) and the
lowest radical scavenging activity (0.02 mg/mL), followed
by pollen, honey, and RJ, in that order. Our findings suggest
a positive correlation between TPC/TFC and antioxidant
potentials of honeybee products, in agreement with earlier
studies (17,39,40).
Chestnut honey (Castanea sativa) is a dark ambercolored product with a high fructose/glucose ratio (>1.52)
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and is used as a medicinal honey in clinics worldwide
due to its high TPC and antioxidant capacity (20,41–43).
We used chestnut honey obtained from the Zonguldak
region of Turkey, which has already been shown to have
higher TPC levels (98.0 mg GAE/100 g honey) than some
blossom honeys in Turkey (43), in order to evaluate its
hepatoprotective effect following CCl4-induced liver
damage. Honeybees use a highly pure composition of
RJ to feed their larvae and young bees owing to its high
nutritional and bioactivity properties. As researchers
reviewed its therapeutic potential, RJ became one of the
most popular natural products in apitherapic applications
(24,39). Several studies have shown that RJ protects cells
against oxidative stress (25,44). Its bioactivity properties
are mainly attributed to high concentrations of fatty acids,
proteins, and phenolic compounds (24). However, TPC
levels among the bee products we analyzed were lowest
in RJ (0.072 mg GAE/g, 13 times less than in honey),
which may suggest that its bioactivity depends not only on
phenolic acids, but also on other constituents (fatty acids,
proteins) within its structure.
The purpose of this study was to evaluate the effects of
bee products on hepatoprotective activities in experimental
rat groups. The experimental animals were exposed to
CCl4 toxicity in order to induce hepatic damage. Seven
different groups were studied. Significant weight loss was
determined in the rats treated with ethanol (Group 2), the
CCl4-exposed group (Group 3), and the pollen (Group
5) and propolis (Group 6) groups. Since the propolis was
dissolved in ethanol for injection, the weight loss in the
propolis-treated animals may be due to the ethanol solvent
rather than to the propolis. We observed no weight loss in
the honey- or RJ-treated groups (Groups 4 and 7), which
may suggest that the rich levels of carbohydrates and other
nutrients in honey and RJ compensated for the weight loss
caused by the liver injury.
Administration of CCl4 at a dose of 0.8 mL kg–1 day–1
leads to severe acute necrosis in the liver, since AST and
ALT activities of plasma enzymes were significantly
elevated in the rats. In addition, microscopic examination
of liver tissues in the CCl4-only group (Group 3) revealed
serious liver necrosis (Figure 1C). Many studies have
reported that CCl4 is a hepatotoxic agent that can induce
lipid peroxidation and cellular damage (8–10,27). Fatty
degeneration in hepatocytes was detected in liver sections
from the CCl4- and ethanol-treated groups. A significant
improvement in these degenerations was evident in the
groups treated with the honeybee products (Groups 4–7).
Kanbur et al. (44) investigated hepatoprotective effects
in paracetamol-induced liver damage and reported a
marked protective effect on liver damage in mice. RJ has
been reported to exhibit hepatoprotective effects against
fumonisin-induced liver damage in rats (25). Cheng et
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al. (18) reported that pollen extracts from Schisandra
chinensis reduced CCl4-induced liver damage in mice.
Ethanolic propolis extract has also been reported to
protect against AlCl3-induced hepatic injury in a mouse
model (40). Chestnut propolis has been reported to exhibit
a protective effect against alcohol-induced liver damage
(16). Dietary honey consumption has been shown to
reduce hepatotoxicity in CCl4-induced liver damage (45).
These studies, and our own results, suggest that honeybee
products have substantial potential applications for the
healing of liver damage to various extents depending on
their antioxidant capacity.
Although our honeybee products exhibited different
levels of antioxidant characteristics, their healing
potentials in liver damage did not differ significantly from
one another. This may be due to their bioavailability and
their absorption by the rats’ gastrointestinal tracts. It has
been reported that honey, propolis, pollen, and RJ possess
different bioavailability properties. Honey exhibited
the highest absorption rate followed by pollen, RJ, and
propolis, in that order (46).

In conclusion, chestnut honey, pollen, propolis, and
RJ are rich in natural antioxidant products. Propolis
exhibited the highest phenolic and flavonoid contents and
thus exhibited more pronounced antioxidant activity in
the FRAP and DPPH assays. Weight loss resulting from
CCl4-induced liver damage was successfully compensated
for by the honey and the RJ, but not by the propolis or the
pollen. Overall, we conclude that honey, propolis, pollen,
and RJ enhance recovery from CCl4-induced liver damage
in a manner partially dependent on their antioxidant
properties and bioavailability, which has been reported in
previous studies. These honeybee products can therefore
be used for the prevention and treatment of various liver
diseases. The mechanism of hepatoprotective activity on
hepatocytes of these bee products requires further in vitro
analyses in future studies.
Acknowledgment
This study was supported by funding from the Scientific
Research Project of Karadeniz Technical University (KTÜBAP 2009.111.002.5).

References
9.

Zhang A, Sun H, Wang X. Recent advances in natural products
from plants for treatment of liver diseases. Eur J Med Chem
2013; 63: 570–577.

Dalton SR, Lee SM, King RN, Nanji AA, Kharbanda KK, Casey
CA, McVicker BL. Carbon tetrachloride-induced liver damage
in asialoglycoprotein receptor-deficient mice. Biochem
Pharmacol 2009; 77: 1283–1290.

10.

3.

Eraslan G, Kanbur M, Silici S, Karabacak M. Beneficial effect
of pine honey on trichlorfon induced some biochemical
alterations in mice. Ecotoxicol Environ Saf 2010; 73: 1084–
1091.

Peng W, Zhang C, Lv H, Zhu J, Zang Y, Pang X, Zhang J, Qin J.
Comparative evaluation of the protective potentials of human
paraoxonase 1 and 3 against CCl4-induced liver injury. Toxicol
Lett 2010; 193: 159–166.

11.

4.

Liu CM, Ma JQ, Sun YZ. Puerarin protects the rat liver against
oxidative stress-mediated DNA damage and apoptosis induced
by lead. Exp Toxicol Pathol 2012; 64: 575–582.

Hegazi AG. Medical importance of bee products. U Bee J 2012;
12: 136–146.

12.

5.

Zhao X, Cong X, Zheng L, Xu L, Yin L, Peng J. Dioscin, a
natural steroid saponin, shows remarkable protective effect
against acetaminophen-induced liver damage in vitro and in
vivo. Toxicol Lett 2012; 214: 69–80.

Campos MG, Webby RF, Markham KR, Mitchell KA, Da
Cunha AP. Age-induced diminution of free radical scavenging
capacity in bee pollens and the contribution of constituent
flavonoids. J Agric Food Chem 2003; 51: 742–745.

13.

Nasuti C, Gabbianelli R, Falcioni G, Cantalamessa F.
Antioxidative and gastroprotective activities of antiinflammatory formulations derived from chestnut honey in
rats. Nut Res 2006; 26: 130–137.

14.

Saral O, Kolayli S. What are the preventative effects of liver
damage of bee products. U Bee J 2012; 12: 147–152.

15.

Inoue S, Koya-Miyata S, Ushio S, Iwaki K, Ikeda M, Kurimoto
M. Royal jelly prolongs the life span of C3H/HeJ mice:
correlation with reduced DNA damage. Exp Gerontol 2003;
38: 965–969.

16.

Kolankaya D, Selmanoğlu G, Sorkun K, Salih B. Protective
effects of Turkish propolis on alcohol-induced serum lipid
changes and liver injury in male rats. Food Chem 2002; 78:
213–217.

1.

Zimmerman HJ. Drug-induced liver disease. Clin Liver Dis
2000; 4: 73–96.

2.

6.

Ferrucci LM, Bell BP, Dhotre KB, Manos MM, Terrault NA,
Zaman A, Murphy RC, VanNess GR, Thomas AR, Bialek SR
et al. Complementary and alternative medicine use in chronic
liver disease patients. J Clin Gastroenterol 2010; 44: 40–45.

7.

Valcheva-Kuzmanova S, Borisova P, Galunska B, Krasnaliev I,
Belcheva A. Hepatoprotective effect of the natural fruit juice
from Aronia melanocarpa on carbon tetrachloride-induced
acute liver damage in rats. Exp Toxicol Pathol 2004; 56: 195–
201.

8.

Basu S. Carbon tetrachloride-induced lipid peroxidation:
eicosanoid formation and their regulation by antioxidant
nutrients. Toxicology 2003; 189: 113–127.

201

SARAL et al. / Turk J Med Sci
17.

Küçük M, Kolaylı S, Karaoğlu Ş, Ulusoy E, Baltacı C, Candan F.
Biological activities and chemical composition of three honeys
of different types from Anatolia. Food Chem 2007; 100: 526–
534.

18.

Cheng N, Ren N, Gao H, Lei X, Zheng J, Cao W. Antioxidant
and hepatoprotective effects of Schisandra chinensis pollen
extract on CCl4-induced acute liver damage in mice. Food
Chem Toxicol 2013; 55: 234–240.

19.

20.

21.

22.

LeBlanc BW, Davis OK, Boue S, DeLucca A, Deeby T.
Antioxidant activity of Sonoran Desert bee pollen. Food Chem
2009; 115: 1299–1305.
Morais M, Moreira L, Feas X, Estevinho LM. Honeybeecollected pollen from five Portuguese Natural Parks:
palynological origin, phenolic content, antioxidant properties
and antimicrobial activity. Food Chem Toxicol 2011; 49: 1096–
1101.
Aliyazicioglu R, Sahin H, Erturk O, Ulusoy E, Kolayli S.
Properties of phenolic composition and biological activity of
propolis from Turkey. Int J Food Prop 2011; 16: 277–287.
Cui K, Lu W, Zhu L, Shen X, Huang J. Caffeic acid phenethyl
ester (CAPE), an active component of propolis, inhibits
Helicobacter pylori peptide deformylase activity. Biochem
Biophys Res Commun 2013; 435: 289–294.

31.

Molyneux P. The use of the stable free radical
diphenylpicrylhyrazyl (DPPH) for estimating antioxidant
activity. Songklanakarin J Sci Technol 2004; 26: 211–219.

32.

Sun Y, Oberley LW, Li Y. A simple method for clinical assay of
superoxide dismutase. Clin Chem 1988; 34: 497–500.

33.

Mihara M, Uchiyama M. Determination of malonaldehyde
precursor in tissues by thiobarbituric acid test. Ann Biochem
1978; 86 : 271–278.

34.

Aebi H. Catalase in vitro. Meth Enzymol 1984; 105: 121–126.

35.

Salomao K, Dantas AP, Borba CM, Campos LC, Machado DG,
Aquino Neto FR, de Castro SL. Chemical composition and
microbicidal activity of extracts from Brazilian and Bulgarian
propolis. Lett Appl Microbiol 2004; 38: 87–92.

36.

Gulcin I, Bursal E, Sehitoglu MH, Bilsel M, Goren AC.
Polyphenol contents and antioxidant activity of lyophilized
aqueous extract of propolis from Erzurum, Turkey. Food
Chem Toxicol 2010; 48: 2227–2238.

37.

Laskar RA, Sk I, Roy N, Begum NA. Antioxidant activity of
Indian propolis and its chemical constituents. Food Chem
2010; 122: 233–237.

38.

Ulusoy E, Kolayli S. Phenolic composition and antioxidant
properties of Anzer bee pollen. J Food Biochem 2013; 38: 73–
82.

23.

Aljadi AM, Yusoff KM. Isolation and identification of phenolic
acids in Malaysian honey with antibacterial property. Turk J
Med Sci 2003; 33: 229–236.

39.

Isidorov VA, Czyżewska U, Jankowska E, Bakier S.
Determination of royal jelly acids in honey. Food Chem 2011;
124: 387–391.

24.

Ramadan MF, Al-Ghamdi A. Bioactive compounds and
health-promoting properties of royal jelly: a review. J Funct
Foods 2012; 4: 39–52.

40.

Turkez H, Yousef MI, Geyikoglu F. Propolis prevents
aluminium-induced genetic and hepatic damages in rat liver.
Food Chem Toxicol 2010; 48: 2741–2746.

25.

El-Nekeety AA, El-Kholy W, Abbas NF, Ebaid A, Amra HA,
Abdel-Wahhab MA. Efficacy of royal jelly against the oxidative
stress of fumonisin in rats. Toxicon 2007; 50: 256–269.

41.

26.

Kamakura M, Mitani N, Fukuda T, Fukushima M. Antifatigue
effect of fresh royal jelly in mice. J Nutr Sci Vitaminol 2001; 47:
394–401.

Sahin H, Can Z, Yildiz O, Kolayli S, Innocenti A, Scozzafava G,
Supuran CT. Inhibition of carbonic anhydrase isozymes I and
II with natural products extracted from plants, mushrooms
and honey. J Enzyme Inhib Med Chem 2012; 27: 395–402.

42.

Sarikaya AO, Ulusoy E, Ozturk N, Tuncel M, Kolayli S.
Antioxidant activity and phenolic acid constituents of chestnut
(Castania sativa Mill.) honey and propolis. J Food Biochem
2009; 33: 470–481.

27.

Yildiz O, Can Z, Saral O, Yulug E, Ozturk F, Aliyazicioglu R,
Canpolat S, Kolayli S. Hepatoprotective potential of chestnut
bee pollen on carbon tetrachloride-induced hepatic damages
in rats. Evid Based Complement Alternat Med 2013; 22: 461–
478.

28.

Singleton VL, Orthofer R, Lamuela-Raventós RM. Analysis of
total phenols and other oxidation substrates and antioxidants
by means of Folin-Ciocalteu reagent. In: Lester P, editor.
Methods in Enzymology. New York, NY, USA: Academic Press;
1999. pp. 152–178.

29.

Chang CC, Yang MH, Wen HM, Chern JC. Estimation of
total flavonoid content in propolis by two complementary
colorimetric methods. J Food Drug Anal 2002; 10: 178–182.

30.

Benzie IF, Strain JJ. Ferric reducing/antioxidant power assay:
direct measure of total antioxidant activity of biological fluids
and modified version for simultaneous measurement of total
antioxidant power and ascorbic acid concentration. Meth
Enzymology 1999; 299: 15–27.

202

43. Can Z, Yildiz O, Sahin H, Tutumtay AT, Silici S, Kolayli S.
An investigation of Turkish honeys; their physico-chemical
properties, antioxidant capacities and phenolic profiles. Food
Chem 2015; 180: 133–141.
44.

Kanbur M, Eraslan G, Beyaz L, Silici S, Liman BC, Altinordulu
S, Atasever A. The effects of royal jelly on liver damage induced
by paracetamol in mice. Exp Toxicol Path 2009; 61: 123–132.

45.

El-Denshary ES, Al-Gahazali MA, Mannaa FA, Salem
HA, Hassan NS, Abdel-Wahhab MA. Dietary honey and
ginseng protect against carbon tetrachloride-induced
hepatonephrotoxicity in rats. Exp Toxicol Path 2012; 64: 753–
760.

46.

Alvarez-Suarez JM, Giampieri F, Battino M. Honey as a source
of dietary antioxidants: structures, bioavailability and evidence
of protective effects against human chronic diseases. Curr Med
Chem 2013; 20: 621–638.

